Related Experiment Video
Updated: Mar 22, 2026

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells
Published on: December 30, 2025
MicroRNA-101 has a suppressive role in osteosarcoma cells through the targeting of c-FOS
Zili Wang1, Rongzhen He1, Hansong Xia1
1Department of Orthopaedic Surgery, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China.
Abstract:
MicroRNAs (miRs) have been implicated in the development and progression of osteosarcoma (OS). However, the underlying mechanism of miR-101 in regulating of the proliferation, migration and invasion of OS cells remains to be elucidated. In the present study, reverse transcription-quantitative polymerase chain reaction data revealed that miR-101 was frequently downregulated in the tissue samples of 12 patients with OS compared with their matched adjacent non-tumor tissues. Furthermore, miR-101 was significantly downregulated in three common OS cell lines, Saos-2, MG63 and U2OS, compared with the human osteoblast cell line, hFOB1.19 (P<0.01). A luciferase reporter assay was also performed and identified c-FOS as a novel target of miR-101 in U2OS cells; overexpression of miR-101 significantly suppressed the protein expression levels of c-FOS, while knockdown of miR-101 significantly enhanced the formers' expression levels in U2OS cells (P<0.01). Independent inhibition of c-FOS and overexpression of miR-101 expression levels significantly suppressed U2OS cell proliferation, migration and invasion (P<0.01). However, overexpression of c-FOS reversed the inhibitory effect of miR-101 upregulation on proliferation, migration and invasion of U2OS cells, suggesting that miR-101 acts as a tumor suppressor in OS cells via targeting of c-FOS. Thus, we propose that the miR-101/c-FOS axis may be a potential therapeutic target for OS.
Insights
MicroRNA-101 (miR-101) is downregulated in osteosarcoma (OS) and suppresses tumor growth. Targeting the miR-101/c-FOS pathway may offer new therapeutic strategies for OS patients.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- MicroRNAs (miRs) play crucial roles in cancer development.
- The specific role of miR-101 in osteosarcoma (OS) progression is not fully understood.
- Investigating miR-101's mechanism in OS is vital for potential therapeutic development.
Purpose of the Study:
- To elucidate the mechanism of miR-101 in regulating osteosarcoma cell proliferation, migration, and invasion.
- To identify novel targets of miR-101 in OS.
- To evaluate the therapeutic potential of the miR-101/c-FOS axis in OS.
Main Methods:
- Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) to measure miR-101 expression in OS tissues and cell lines.
- Luciferase reporter assay to identify and validate c-FOS as a direct target of miR-101.
- Cell proliferation, migration, and invasion assays following miR-101 or c-FOS manipulation.
Main Results:
- miR-101 was significantly downregulated in OS tissues and cell lines compared to normal controls.
- c-FOS was identified as a direct target of miR-101, with miR-101 negatively regulating c-FOS protein expression.
- Overexpression of miR-101 or inhibition of c-FOS suppressed OS cell proliferation, migration, and invasion.
- Upregulation of c-FOS reversed the tumor-suppressive effects of miR-101.
Conclusions:
- miR-101 functions as a tumor suppressor in osteosarcoma by targeting c-FOS.
- The miR-101/c-FOS signaling pathway is a potential therapeutic target for osteosarcoma.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Abnormal Proliferation

